Indaptus Therapeutics INDP
NASDAQ INDP
$3.21 +0.31 (+10.69%)
At close: Nov 11, 2026 · 4:00 PM EST

Indaptus Therapeutics (INDP) Other Non-Current Liabilities (2020 - 2025)

Updated

Indaptus Therapeutics (INDP) recorded Other Non-Current Liabilities of $716,000 in Q2 2021, up 1.6% from the prior quarter.

Analysis

Indaptus Therapeutics (INDP) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends

At the end of FY2020, Indaptus Therapeutics reported Other Non-Current Liabilities of $691,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Indaptus Therapeutics 185.93 Mn 158.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.94 Mn
Dec 31, 2024 288,756.00
Dec 31, 2023 261,052.00
Dec 31, 2022 234,350.00
Dec 31, 2021 1.88 Mn
Jun 30, 2021 716,000.00
Mar 31, 2021 705,000.00
Dec 31, 2020 691,000.00
API Access

Indaptus Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INDP&period=max&api_key=YOUR_API_KEY